Regulation & Law
Telehealth Documentation: Gaps Watchdogs Must Fix
Telehealth documentation failures across neurology, opioid care, and drug prescribing expose patients to serious risk. Here's what the research shows.
Beat
Regulation & Law
The rules that govern online prescribing — FDA, DEA, state medical boards, and the compounding landscape — translated for patients.
Regulation & Law
Telehealth Prescribing: Gaps Watchdogs Must See
New research exposes telehealth prescribing blind spots across opioid therapy, ketamine, peptides, and PrEP. Here's what regulators and patients need to know.
Regulation & Law
Telehealth Drug Oversight: Gaps Watchdogs See
Telehealth drug oversight has critical gaps. A watchdog report examines state-level inconsistencies, liability risks, and documentation failures across the U.S.
Regulation & Law
Telehealth Drug Rules: Gaps Watchdogs Must Fix
Telehealth drug rules vary wildly by state, leaving patients exposed. A watchdog look at the regulatory gaps research says demand urgent fixes.
Regulation & Law
Telehealth Regulation: Gaps the Data Expose
Telehealth regulation lags behind rapid growth. New research reveals documentation failures, liability blind spots, and uneven state oversight threatening patients.
Regulation & Law
Telehealth Regulation Gaps Risk Patient Safety
Telehealth regulation gaps let unvetted drugs reach patients with little oversight. See what watchdog research reveals and why experts urge reform.
Regulation & Law
Why compounded GLP-1s got harder to buy: the shortage-status story
For a while, drug shortages made compounded semaglutide widely available online. When the FDA declared the shortages over, the legal ground shifted under those products.
Regulation & Law
Telehealth prescribing across state lines: what the law actually requires
The clinician who prescribes to you online generally must be licensed in YOUR state — not theirs. Here's how cross-state rules, compacts and the DEA extension really work.